After review of additional data, the 2023 ACC/AHA Guidelines for the Management of Patients with Chronic Coronary Disease published a strong (Class 1, LoE A) recommendation for the use of GLP-1 RA with proven cardiovascular benefits in patients with diabetes and chronic coronary disease to reduce the risk of MACE
Form: Subcutaneous injection Strength: 0.25 mg or 0.5 mg dose pen 1 mg dose pen 2 mg dose pen 2
It is the improvement in insulin sensitivity that accompanies it
While they can be effective for some, many people find them difficult to sustain long-term due to cravings, plateaus, and the constant battle with willpower
Some people feel burping, reflux, bloating, or that heavy food is just sitting there feeling
Additionally, sunscreen should be reapplied every ninety minutes for best coverage